Raman spectroscopic investigation of atorvastatin, amlodipine, and both on atherosclerotic plaque development in APOE*3 Leiden transgenic mice

Atherosclerosis

Volumn 164, Issue 1, 2002, Pages 65-71

  Van de Poll, Sweder W E ^a,b   Delsingl,, Dianne J M ^c   Jukema, J Wouter ^a   Princen, Hans M G ^c   Havekes, Louis M ^c   Puppels, Gerwin J ^d   Van der Laarse, Arnoud ^a,b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^c TNO   (Netherlands)

^d ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Atherosclerosis; Calcification; Calcium channel inhibitors; Cholesterol; Plaque; Raman spectroscopy; Statins

Indexed keywords

AMLODIPINE; ATORVASTATIN; ANTIHYPERTENSIVE AGENT; APOLIPOPROTEIN E; APOLIPOPROTEIN E3; APOLIPOPROTEIN E3 (LEIDEIN); CHOLESTEROL; HEPTANOIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PYRROLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ARCH; ARTICLE; ATHEROSCLEROTIC PLAQUE; AUTOPSY; CALCIFICATION; CHOLESTEROL DIET; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; DRUG POTENTIATION; MALE; MINERALIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAMAN SPECTROMETRY; TRANSGENIC MOUSE; TREATMENT OUTCOME; ANIMAL; AORTA; ARTERIOSCLEROSIS; DISEASE MODEL; GENETICS; METHODOLOGY; PATHOLOGY;

AMLODIPINE; ANIMAL; ANTIHYPERTENSIVE AGENTS; AORTA; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; CHOLESTEROL; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MICE; MICE, TRANSGENIC; PYRROLES; SPECTRUM ANALYSIS, RAMAN; ANIMALS; APOLIPOPROTEIN E3;

EID: 0035996579     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(02)00055-2     Document Type: Article

References (31)

1. Statins do more than just lower cholesterol
2. Effects of statins on vascular wall: Vasomotor function, inflammation, and plaque stability
3. Atherosclerosis: Prevention by agents not affecting abnormal levels of blood lipids
4. Suppression of atherogenesis in cholesterol-fed rabbit treated with nifedipine
5. A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis
6. Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the international nifedipine trial on antiatherosclerotic therapy
7. Cholesterol, calcium and atherosclerosis: Is there a role for calcium channel blockers in atheroprotection?
8. Membrane antioxidant effects of the charged dihydropyridine calcium antagonist amlodipine
9. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events
10. Review of preclinical data of calcium channel blockers and atherosclerosis
11. Calcium antagonists and atherosclerosis. Experimental evidence
12. Evidence for a synergistic effect of calcium channel blockers with lipid-lowering therapy in retarding progression of coronary atherosclerosis in symptomatic patients with normal to moderately raised cholesterol levels. The REGRESS Study Group
13. Raman spectroscopic evaluation of the effects of diet and lipid-lowering therapy on atherosclerotic plaque development in mice
14. In vivo determination of the molecular composition of artery wall by intravascular Raman spectroscopy
15. Vulnerable plaque: Pathobiology and clinical implications
16. Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice
17. Apolipoprotein E*3-Leiden transgenic mice as a test model for hypolipidaemic drugs
18. Progression and regression of atherosclerosis in APOE3-Leiden transgenic mice: An immunohistochemical study
19. Quantitative assessment of aortic atherosclerosis in APOE*3 Leiden transgenic mice and its relationship to serum cholesterol exposure
20. Quantitation of atherosclerosis in murine models: Correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice
21. Cellular free cholesterol in HepG2 cells is only partially available for downregulation
22. Determination of human coronary artery composition by Raman spectroscopy
23. Histopathology of human coronary atherosclerosis by quantifying its chemical composition with Raman spectroscopy
24. Raman spectroscopy for quantifying cholesterol in intact coronary artery wall
25. Reduction of serum cholesterol levels alters lesional composition of atherosclerotic plaques. Effect of pravastatin sodium on atherosclerosis in mature WHHL rabbits
26. Antiatherosclerotic activity of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase in cholesterol-fed rabbits: A biochemical and morphological evaluation
27. Regression of poloxamer 407-induced atherosclerotic lesions in C57BL/6 mice using atorvastatin
28. Verapamil suppresses atherosclerosis in cholesterol-fed rabbits
29. Calcium antagonists suppress atherogenesis in aorta but not in the intramural coronary arteries of cholesterol-fed rabbits
30. Biology of calcification in vascular cells: Intima versus media
31. Calcification of vascular smooth muscle cell cultures: Inhibition by osteopontin